Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Non-investigational
Locations
8
United States
Lundquist Inst BioMed at Harbor
Torrance, California, United States
Rocky Mountain Cancer Centers
Denver, Colorado, United States
Johns Hopkins University
Washington D.C., District of Columbia, United States
Duke Clinical Research Institute
Durham, North Carolina, United States
Oncology Hematology Care Inc
Cincinnati, Ohio, United States
Sarah Cannon Research Institute
Nashville, Tennessee, United States
Start Date
February 6, 2024
Primary Completion Date
March 3, 2028
Completion Date
March 3, 2028
Last Updated
April 1, 2026
Novartis Pharmaceuticals
CONTACT
Lead Sponsor
Novartis Pharmaceuticals
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions